Literature DB >> 23689985

In vitro and in vivo evaluation of the caspase-3 substrate-based radiotracer [(18)F]-CP18 for PET imaging of apoptosis in tumors.

Chun-Fang Xia1, Gang Chen, Umesh Gangadharmath, Luis F Gomez, Qianwa Liang, Fanrong Mu, Vani P Mocharla, Helen Su, A Katrin Szardenings, Joseph C Walsh, Tieming Zhao, Hartmuth C Kolb.   

Abstract

PURPOSE: A novel caspase-3 substrate-based probe [(18)F]-CP18 was evaluated as an in vivo positron emission tomography (PET) imaging agent for monitoring apoptosis in tumors.
METHODS: Uptake of [(18)F]-CP18 in cell assays and tumors was measured. Caspase-3/7 activities in cell lysates and tumor homogenates were determined. Autoradiography,Terminal deoxynucleotidyl transferase dUTP nick end labeling (TUNEL), and cleaved caspase-3 immunostaining were performed on adjacent tumor sections to identify areas of apoptosis.
RESULTS: The in vitro cell assays showed caspase-3-dependent uptake of [(18)F]-CP18 in tumor cells when treated with an apoptosis inducer. The in vivo microPET imaging signal of [(18)F]-CP18 in xenograft tumors correlated with the ex vivo caspase-3/7 activities in these tumors. Furthermore, tumor autoradiographies of [(18)F]-CP18 in tumor sections matched adjacent sections stained by TUNEL and caspase-3 immunohistochemistry (IHC).
CONCLUSIONS: [(18)F]-CP18 demonstrated high affinity and selectivity for activated caspase-3 both in vitro and in vivo, and the results support [(18)F]-CP18 as a promising new PET imaging agent for apoptosis.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23689985     DOI: 10.1007/s11307-013-0646-7

Source DB:  PubMed          Journal:  Mol Imaging Biol        ISSN: 1536-1632            Impact factor:   3.488


  28 in total

Review 1.  Molecular mechanisms of caspase regulation during apoptosis.

Authors:  Stefan J Riedl; Yigong Shi
Journal:  Nat Rev Mol Cell Biol       Date:  2004-11       Impact factor: 94.444

2.  The nonpeptidyl caspase binding radioligand (S)-1-(4-(2-[18F]Fluoroethoxy)-benzyl)-5-[1-(2-methoxymethylpyrrolidinyl)sulfonyl]isatin ([18F]CbR) as potential positron emission tomography-compatible apoptosis imaging agent.

Authors:  A Faust; S Wagner; M P Law; S Hermann; U Schnöckel; P Keul; O Schober; M Schäfers; B Levkau; K Kopka
Journal:  Q J Nucl Med Mol Imaging       Date:  2007-03       Impact factor: 2.346

3.  Assessment of response of brain metastases to radiotherapy by PET imaging of apoptosis with ¹⁸F-ML-10.

Authors:  Aaron M Allen; Miri Ben-Ami; Ayelet Reshef; Adam Steinmetz; Yulia Kundel; Edna Inbar; Ruth Djaldetti; Tal Davidson; Eyal Fenig; Ilan Ziv
Journal:  Eur J Nucl Med Mol Imaging       Date:  2012-06-15       Impact factor: 9.236

Review 4.  From RECIST to PERCIST: Evolving Considerations for PET response criteria in solid tumors.

Authors:  Richard L Wahl; Heather Jacene; Yvette Kasamon; Martin A Lodge
Journal:  J Nucl Med       Date:  2009-05       Impact factor: 10.057

5.  99mTc-HYNIC Annexin-V imaging of primary head and neck carcinoma.

Authors:  Hubert Vermeersch; David Loose; Christophe Lahorte; Kris Mervillie; Rudi Dierckx; Neil Steinmetz; Jean-Luc Vanderheyden; Claude Cuvelier; Guido Slegers; Christophe Van de Wiele
Journal:  Nucl Med Commun       Date:  2004-03       Impact factor: 1.690

6.  Imaging acute cardiac cell death: temporal and spatial distribution of 99mTc-labeled C2A in the area at risk after myocardial ischemia and reperfusion.

Authors:  Xiaoguang Zhu; Zhixin Li; Ming Zhao
Journal:  J Nucl Med       Date:  2007-06       Impact factor: 10.057

7.  Safety, biodistribution, and dosimetry of 99mTc-HYNIC-annexin V, a novel human recombinant annexin V for human application.

Authors:  Gerrit J Kemerink; Xuan Liu; Davy Kieffer; Sarah Ceyssens; Luc Mortelmans; Alfons M Verbruggen; Neil D Steinmetz; Jean-Luc Vanderheyden; Allan M Green; Kristin Verbeke
Journal:  J Nucl Med       Date:  2003-06       Impact factor: 10.057

8.  Caspase 3-mediated stimulation of tumor cell repopulation during cancer radiotherapy.

Authors:  Qian Huang; Fang Li; Xinjian Liu; Wenrong Li; Wei Shi; Fei-Fei Liu; Brian O'Sullivan; Zhimin He; Yuanlin Peng; Aik-Choon Tan; Ling Zhou; Jingping Shen; Gangwen Han; Xiao-Jing Wang; Jackie Thorburn; Andrew Thorburn; Antonio Jimeno; David Raben; Joel S Bedford; Chuan-Yuan Li
Journal:  Nat Med       Date:  2011-07-03       Impact factor: 53.440

9.  Hepatocellular carcinomas with a high proliferation index and a low degree of apoptosis and necrosis are associated with a shortened survival.

Authors:  Y Soini; N Virkajärvi; V P Lehto; P Pääkkö
Journal:  Br J Cancer       Date:  1996-05       Impact factor: 7.640

10.  99mTc Hynic-rh-Annexin V scintigraphy for in vivo imaging of apoptosis in patients with head and neck cancer treated with chemoradiotherapy.

Authors:  Frank J P Hoebers; Marina Kartachova; Josien de Bois; Michiel W M van den Brekel; Harm van Tinteren; Marcel van Herk; Coen R N Rasch; Renato A Valdés Olmos; Marcel Verheij
Journal:  Eur J Nucl Med Mol Imaging       Date:  2007-11-10       Impact factor: 9.236

View more
  13 in total

Review 1.  The Continuing Evolution of Molecular Functional Imaging in Clinical Oncology: The Road to Precision Medicine and Radiogenomics (Part I).

Authors:  Tanvi Vaidya; Archi Agrawal; Shivani Mahajan; Meenakshi H Thakur; Abhishek Mahajan
Journal:  Mol Diagn Ther       Date:  2019-02       Impact factor: 4.074

2.  Design of a functional cyclic HSV1-TK reporter and its application to PET imaging of apoptosis.

Authors:  Zhe Wang; Fu Wang; Naoki Hida; Dale O Kiesewetter; Jie Tian; Gang Niu; Xiaoyuan Chen
Journal:  Nat Protoc       Date:  2015-04-30       Impact factor: 13.491

3.  Caspase-responsive smart gadolinium-based contrast agent for magnetic resonance imaging of drug-induced apoptosis.

Authors:  Deju Ye; Adam J Shuhendler; Prachi Pandit; Kimberly D Brewer; Sui Seng Tee; Lina Cui; Grigory Tikhomirov; Brian Rutt; Jianghong Rao
Journal:  Chem Sci       Date:  2014-10-01       Impact factor: 9.825

4.  Evaluation of [18F]CP18 as a Substrate-Based Apoptosis Imaging Agent for the Assessment of Early Treatment Response in Oncology.

Authors:  Sara Rapic; Christel Vangestel; Filipe Elvas; Jeroen Verhaeghe; Tim Van den Wyngaert; Leonie Wyffels; Patrick Pauwels; Steven Staelens; Sigrid Stroobants
Journal:  Mol Imaging Biol       Date:  2017-08       Impact factor: 3.488

5.  Noninvasive molecular imaging of apoptosis in a mouse model of anthracycline-induced cardiotoxicity.

Authors:  Helen Su; Natalia Gorodny; Luis Felipe Gomez; Umesh Gangadharmath; Fanrong Mu; Gang Chen; Joseph C Walsh; Katrin Szardenings; Hartmuth C Kolb; Balaji Tamarappoo
Journal:  Circ Cardiovasc Imaging       Date:  2015-02       Impact factor: 7.792

6.  A peptide-based positron emission tomography probe for in vivo detection of caspase activity in apoptotic cells.

Authors:  Matthew R Hight; Yiu-Yin Cheung; Michael L Nickels; Eric S Dawson; Ping Zhao; Samir Saleh; Jason R Buck; Dewei Tang; M Kay Washington; Robert J Coffey; H Charles Manning
Journal:  Clin Cancer Res       Date:  2014-02-26       Impact factor: 12.531

7.  Mistiming Death: Modeling the Time-Domain Variability of Tumor Apoptosis and Implications for Molecular Imaging of Cell Death.

Authors:  Seth T Gammon; Brian J Engel; Gregory J Gores; Erik Cressman; David Piwnica-Worms; Steven W Millward
Journal:  Mol Imaging Biol       Date:  2020-10       Impact factor: 3.488

Review 8.  Molecular imaging of apoptosis: from micro to macro.

Authors:  Wenbin Zeng; Xiaobo Wang; Pengfei Xu; Gang Liu; Henry S Eden; Xiaoyuan Chen
Journal:  Theranostics       Date:  2015-02-20       Impact factor: 11.556

Review 9.  SPECT and PET radiopharmaceuticals for molecular imaging of apoptosis: from bench to clinic.

Authors:  Xiaobo Wang; Han Feng; Shichao Zhao; Junling Xu; Xinyu Wu; Jing Cui; Ying Zhang; Yuhua Qin; Zhiguo Liu; Tang Gao; Yongju Gao; Wenbin Zeng
Journal:  Oncotarget       Date:  2017-03-21

Review 10.  Avenues to molecular imaging of dying cells: Focus on cancer.

Authors:  Anna A Rybczynska; Hendrikus H Boersma; Steven de Jong; Jourik A Gietema; Walter Noordzij; Rudi A J O Dierckx; Philip H Elsinga; Aren van Waarde
Journal:  Med Res Rev       Date:  2018-03-12       Impact factor: 12.944

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.